Hypha Discovery announces “One-Stop Metabolite Shop” solution to support pharmaceutical and agrochemical R&D

SLOUGH, UK - Dec 3, 2019 - Hypha Discovery Limited, a leading specialist CRO, has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug metabolites to pharmaceutical and agrochemical companies worldwide

TrialScope Launches Clinical Trials Website for EMD Serono

JERSEY CITY, NJ, UNITED STATES - Dec 2, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has worked with EMD Serono, the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, to launch a new website, https://clinicaltrials

One Nucleus announces finalists of the BioNewsRound Award

LONDON, UK - Nov 28, 2019 - One Nucleus reveals the finalists of its annual BioNewsRound Award, recognising life science companies that have announced exciting developments for patients and the sector

Creative Peptides Provides Photo Cross Linkers for Custom Labeling in Peptide Modification

NY, NY, UNITED STATES - Nov 28, 2019 - The global leading peptide supplier Creative Peptides announces to release a product line of photo cross linkers for researchers who are engaged with custom labeling, peptide bioconjugation as well as peptide modification

Enzymes for Cancer Treatment Manufactured by Creative Enzymes Have Set New Pace for Medical Science

NEW YORK, NY - Nov 28, 2019 - Creative Enzymes, a cutting-edge enzyme product and service provider based in NY, USA, has recently published enzymes for cancer treatment to help scientists in the area of medicine

BOC Sciences Rearranges Chemical Analysis and Purification Service for Drug Discovery Projects

SHIRLEY, NY, NY, UNITED STATES - Nov 28, 2019 - In response to the ever-increasing demand in new drug discovery and development, medicinal chemistry has progressed at a fast pace during the last ten years

Signant Health Joins the Association of Clinical Research Organizations (ACRO) to Add a Technology Perspective to Industry Conversations

PHILADELPHIA, PA - Nov 27, 2019 - Signant Health announced today that it has joined the non-profit Association of Clinical Research Organizations (ACRO)

Prokarium announces MHRA acceptance to run Phase I trial of lead vaccine against enteric fever

LONDON, UK - Nov 26, 2019 - Prokarium, a private biotechnology company developing vaccines against infectious diseases and immunotherapy for solid tumors, has received Clinical Trial Authorization (CTA) acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to run a first-in-human Phase I trial with Entervax™, a bivalent vaccine against enteric fever

SAKOR Technologies Announces Dynamometer Line for Testing Electric Motor Efficiency to Meet International Environmental Standards

OWOSSO, MI, UNITED STATES - Nov 25, 2019 - For Immediate ReleaseContact:          Judi Handel                        McNeil, Gray & Rice                        617-367-0100 ext

Debiopharm Implements Dotmatics to Improve Data-Driven Decision-Making

BISHOP'S STORTFORD, UNITED KINGDOM - Nov 25, 2019 - Debiopharm International SA, the drug development company focused on oncology and infectious diseases, has implemented tools from Dotmatics, a leading provider of scientific informatics solutions and services, to re-engineer its data management processes to support its continuous growth

Potential findings on whole genome sequencing for cancer treatment was made

SHIRLEY, NY, UNITED STATES - Nov 25, 2019 - In recent years, individualized treatments will benefit more cancer patients as the time and cost of whole genome sequencing decreases

Spring Bank Announces Dosing of Patients in Phase 1 Clinical Trial of IV-Administered STING Agonist, SB 11285

HOPKINTON, MA, UNITED STATES - Nov 20, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has initiated dosing patients in a Phase 1 trial of SB 11285, the company’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist

Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution

PRINCETON, NJ - Nov 21, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the availability of PK Submit™, a technology solution for automating the creation of PK Clinical Data Interchange Standards Consortium (CDISC) domains during Non-Compartmental Analysis (NCA)

Elsevier joins forces with Food and Drug Administration to build predictive drug-induced liver injury AI algorithm

NEW YORK, NY - Nov 21, 2019 - Elsevier, a global information analytics business specializing in science and health, has entered into a Collaborative Research and Development Agreement (CRADA) with the National Center for Toxicological Research (NCTR) at the Food and Drug Administration (FDA)

Creative Proteomics Has Made Targeted Metabolomics Service More Perfect

SHIRLEY, NY - Nov 21, 2019 - November 21, 2019, as an integrated company and leading supplier in the field of proteomics, metabolomics, glycomics, and bioinformatics analysis services, Creative Proteomics has introduced its newly-updated service--targeted metabolomics to assist biotech researchers of their clients

Accumen Launches New Website to Showcase Its Expanded Range of Technologies and Services to Optimize Healthcare Performance

PHOENIX, AZ - Nov 20, 2019 - Accumen Inc., the leader in healthcare performance, today announced the launch of its new website at www

Mologic launches clinical trial for validation of point-of-care COPD exacerbation alert system

BEDFORDSHIRE, UNITED KINGDOM - Nov 20, 2019 -

• COPE-WEL study aims to validate Headstart® test for early detection and monitoring of pulmonary exacerbation of COPD
• Headstart is a non-invasive self-test that detects lung biomarkers in the urine
• Observational, multi-centre validation trial carried out in collaboration with a consortium of leading clinicians and clinical centres

Optibrium collaborates with Enamine and BioSolveIT to add REAL Space Search Tool to StarDrop

CAMBRIDGE, UNITED KINGDOM - Nov 19, 2019 - Optibrium™, BioSolveIT™ and Enamine™, leading providers of software and services for drug discovery, today announce a three-way collaboration enabling efficient search of Enamine’s REAL Space directly from within Optibrium’s StarDrop™ software

Creative Biolabs Announced cd25 Monoclonal Antibody for Research Use

SHIRLEY, NY - Nov 19, 2019 - November 19, 2019, as a leading supplier in the recombinant antibody field, Creative Biolabs aims to provide high-quality services and products to clients in the academia and industry fields all over the world

ScaleMatrix’ DDC Technology Enables Enterprises to Deploy 13 PFLOP NVIDIA DGX-powered ‘AI Anywhere’ Infrastructure with Flexible, ‘No Data Center Required’ Design

DENVER, CO - Nov 18, 2019 - ScaleMatrix, through its subsidiary company, DDC, the global leader in providing scalable data center-to-edge solutions based on its patented Dynamic Density Control™ (DDC) cabinet technology, today announced that it is collaborating with NVIDIA and Microway to deliver SKUs for an 8 petaFLOPS and a 13 petaFLOPS 'Supercomputer Anywhere' solution using its DDC S-Series cabinetsx